WEBINAR SERIES—Challenges and Opportunities for Treatment of Metastatic Breast Cancer

February 5, 2025
11 a.m. EST

Invasive breast cancer is a major cause of disease and death among women. Triple-negative breast cancer, a subtype of breast cancer that is clinically aggressive with high rates of metastasis and recurrence, disproportionately affects women of African descent and carriers of germline BRCA and PALB2 mutations. Amongst younger patients with breast cancer, the triple-negative subtypes are associated with higher pathologic stage and worse long-term survival. 

In this webinar, Marsha Rosner, PhD, of the University of Chicago, will present some of the key challenges of trying to eliminate metastatic breast cancer. She will present different strategies for trying to effectively target metastatic disease and based upon her work, some novel approaches to addressing these problems. 

Key topics include: 

• Understanding the genetic and nongenetic drivers of metastatic breast cancer. 
• Exploring the limitations of current approaches to treatment of metastatic breast cancer. 
• Considering other strategies for targeting breast cancer.

Speaker

Marsha Rosner, PhD
Professor, University of Chicago

Marsha Rich Rosner, PhD, FAAAS, is the Charles B. Huggins Distinguished Service Professor at the University of Chicago. She was founder and first chair of the University of Chicago’s graduate program in cancer biology and is a past chair of the university’s Ben May Department for Cancer Research. The Rosner laboratory’s focus is to identify and characterize key regulators of tumor growth and metastasis, particularly in triple-negative breast cancer, that could lead to novel therapeutic strategies.